Poway, CA (PRWEB) June 11, 2014
Founder and CEO of Vet-Stem, Inc., a leading Regenerative Veterinary Medicine company, Robert J. Harman, DVM presented at The Orthobiologic Institute (TOBI) PRP (Platelet Rich Plasma) and Regenerative Medicine Symposium June 6-7 in Las Vegas. The Symposium with Cadaver Lab boasts over 20 lectures from world-renowned experts in biologics.
Dr. Harman will be presenting on The Future of Biologics: Signposts from Equine Therapies, drawing on a decade of experience developing new products in the Regenerative Veterinary Medicine industry with Vet-Stem, and overseeing the completion of more than 1,000 contract research projects for the development of veterinary and human biotechnology products over his entire career. More recently Dr. Harman brought to the veterinary market Vet-Stem’s GenesisCS-2 PRP Kit. The kit is optimized for equine use, to provide a rich source of autologous growth factors and bio-scaffolding for use in an area of acute injury, mainly in tendons and ligaments.
Many human medicine practices of the future are first proven in veterinary medicine, with typical use of products and validation from animal data being the flagship for human approvals and protocols. Dr. Harman’s company is leading its industry in science-based literature including peer-reviewed studies to prove efficacy and to identify best practices in Regenerative Veterinary Medicine.
TOBI was established to share best practices in cutting-edge PRP and regenerative medicine therapies, drawing global opportunities for physicians to connect within the rapidly growing field. It strives to raise the standards of education and training with intensive hands-on programs and world-class informational curriculums. Courses are intended for Physiatrists, Sports Medicine Physicians, Orthopedists, Rheumatologists and more; addressing areas of the body including shoulder, elbow, wrist/hand, hip, knee, ankle/foot.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.